Total Payments
$6,996
2024 Payments
$769.28
Companies
22
Transactions
171
Medicare Patients
4,403
Medicare Billing
$271,335
Payment Breakdown by Category
Food & Beverage$5,209 (74.5%)
Travel$1,787 (25.5%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,209 | 170 | 74.5% |
| Travel and Lodging | $1,787 | 1 | 25.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, Inc. | $2,521 | 18 | $0 (2022) |
| Alcon Vision LLC | $678.14 | 17 | $0 (2024) |
| Allergan, Inc. | $642.16 | 12 | $0 (2022) |
| Oyster Point Pharma, Inc. | $463.67 | 13 | $0 (2024) |
| Sun Pharmaceutical Industries Inc. | $420.69 | 6 | $0 (2022) |
| Shire North American Group Inc | $348.68 | 20 | $0 (2019) |
| Kala Pharmaceuticals, Inc. | $302.82 | 33 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $250.80 | 6 | $0 (2021) |
| Aerie Pharmaceuticals, Inc. | $237.91 | 9 | $0 (2021) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $220.04 | 4 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $769.28 | 30 | Oyster Point Pharma, Inc. ($246.12) |
| 2023 | $437.27 | 11 | Oyster Point Pharma, Inc. ($217.55) |
| 2022 | $567.79 | 10 | Johnson & Johnson Surgical Vision, Inc. ($198.29) |
| 2021 | $775.48 | 35 | Alcon Vision LLC ($262.07) |
| 2020 | $451.83 | 24 | Sun Pharmaceutical Industries Inc. ($125.00) |
| 2019 | $2,849 | 28 | Johnson & Johnson Surgical Vision, Inc. ($2,154) |
| 2018 | $438.21 | 12 | Novartis Pharmaceuticals Corporation ($170.12) |
| 2017 | $707.06 | 21 | Allergan Inc. ($333.39) |
All Payment Transactions
171 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $22.68 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 12/09/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | Cash or cash equivalent | $23.07 | General |
| 11/21/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | In-kind items and services | $23.07 | General |
| 11/20/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $23.55 | General |
| Category: Dry eyes | ||||||
| 10/30/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $23.77 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 10/29/2024 | Alcon Vision LLC | EYSUVIS (Drug) | Food and Beverage | In-kind items and services | $5.54 | General |
| Category: Ophthalmology | ||||||
| 10/08/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $16.71 | General |
| Category: Dry eyes | ||||||
| 09/19/2024 | Alcon Vision LLC | Rocklatan (Drug) | Food and Beverage | In-kind items and services | $8.25 | General |
| Category: Ophthalmology | ||||||
| 09/11/2024 | Alcon Vision LLC | HYDRUS Microstent (Device) | Food and Beverage | In-kind items and services | $149.99 | General |
| Category: Ophthalmology | ||||||
| 09/10/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $23.36 | General |
| Category: Dry eyes | ||||||
| 08/27/2024 | Alcon Vision LLC | EYSUVIS (Drug) | Food and Beverage | In-kind items and services | $7.09 | General |
| Category: Ophthalmology | ||||||
| 08/27/2024 | Alcon Vision LLC | EYSUVIS (Drug) | Food and Beverage | In-kind items and services | $6.54 | General |
| Category: Ophthalmology | ||||||
| 08/20/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $19.57 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 08/13/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $13.78 | General |
| Category: Dry eyes | ||||||
| 06/13/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $1.95 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 06/04/2024 | Alcon Vision LLC | EYSUVIS (Drug) | Food and Beverage | In-kind items and services | $6.52 | General |
| Category: Ophthalmology | ||||||
| 06/03/2024 | Alcon Vision LLC | EYSUVIS (Drug) | Food and Beverage | In-kind items and services | $11.73 | General |
| Category: Ophthalmology | ||||||
| 05/21/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Dry eyes | ||||||
| 05/14/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $15.31 | General |
| Category: Dry eyes | ||||||
| 05/12/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | In-kind items and services | $20.02 | General |
| 04/15/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | In-kind items and services | $20.80 | General |
| 04/08/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $4.53 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 04/02/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: Dry eyes | ||||||
| 03/12/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $108.20 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 03/04/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | In-kind items and services | $14.36 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 517 | 580 | $71,230 | $37,990 |
| 2022 | 9 | 340 | 361 | $44,587 | $23,319 |
| 2021 | 9 | 1,772 | 2,862 | $262,453 | $115,490 |
| 2020 | 12 | 1,774 | 2,746 | $243,839 | $94,537 |
Total Patients
4,403
Total Services
6,549
Medicare Billing
$271,335
Procedure Codes
39
All Medicare Procedures & Services
39 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 92004 | New patient complete exam of visual system | Office | 2023 | 133 | 133 | $19,285 | $10,927 | 56.7% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 127 | 127 | $18,415 | $10,797 | 58.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 83 | 126 | $12,600 | $7,455 | 59.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 38 | 41 | $5,125 | $3,345 | 65.3% |
| 66984 | Removal of cataract with insertion of prosthetic lens | Office | 2023 | 13 | 24 | $4,200 | $1,771 | 42.2% |
| 92250 | Photography of the retina | Office | 2023 | 61 | 61 | $4,575 | $1,611 | 35.2% |
| 92134 | Imaging of retina | Office | 2023 | 24 | 28 | $3,080 | $798.25 | 25.9% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 13 | 15 | $1,200 | $692.58 | 57.7% |
| 92133 | Imaging of optic nerve | Office | 2023 | 25 | 25 | $2,750 | $592.63 | 21.6% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 126 | 126 | $18,270 | $10,356 | 56.7% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 82 | 83 | $12,035 | $5,629 | 46.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 42 | 57 | $5,720 | $3,739 | 65.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 18 | 18 | $2,250 | $1,568 | 69.7% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 13 | 15 | $1,200 | $655.40 | 54.6% |
| 92250 | Photography of the retina | Office | 2022 | 15 | 15 | $1,125 | $439.90 | 39.1% |
| 92134 | Imaging of retina | Office | 2022 | 14 | 16 | $1,760 | $423.12 | 24.0% |
| 92133 | Imaging of optic nerve | Office | 2022 | 17 | 18 | $1,980 | $397.48 | 20.1% |
| 92145 | Measurement of corneal pressure | Office | 2022 | 13 | 13 | $247.00 | $110.32 | 44.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 446 | 479 | $80,629 | $40,422 | 50.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 310 | 444 | $50,700 | $27,974 | 55.2% |
| 83861 | Microfluid analysis of tears | Office | 2021 | 296 | 817 | $20,450 | $18,101 | 88.5% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 73 | 73 | $19,564 | $8,558 | 43.7% |
| 83516 | Analysis of substance using immunoassay technique, multiple step method | Office | 2021 | 236 | 614 | $15,350 | $6,967 | 45.4% |
| 92083 | Measurement of field of vision during daylight conditions, extended examination | Office | 2021 | 127 | 136 | $18,360 | $6,092 | 33.2% |
| 92133 | Diagnostic imaging of optic nerve of eye | Office | 2021 | 149 | 150 | $30,000 | $3,871 | 12.9% |
About Dr. Mackenzie Macintyre, OD
Dr. Mackenzie Macintyre, OD is a Optometrist healthcare provider based in Sparks, Nevada. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/19/2011. The National Provider Identifier (NPI) number assigned to this provider is 1326323478.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mackenzie Macintyre, OD has received a total of $6,996 in payments from pharmaceutical and medical device companies, with $769.28 received in 2024. These payments were reported across 171 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($5,209).
As a Medicare-enrolled provider, Macintyre has provided services to 4,403 Medicare beneficiaries, totaling 6,549 services with total Medicare billing of $271,335. Data is available for 4 years (2020–2023), covering 39 distinct procedure/service records.
Ad
Practice Information
- Specialty Optometrist
- Location Sparks, NV
- Active Since 10/19/2011
- Last Updated 07/21/2022
- Taxonomy Code 152W00000X
- Entity Type Individual
- NPI Number 1326323478
Products in Payments
- Tecnis 1-piece IOL (Device) $2,279
- TYRVAYA (Drug) $463.67
- XIIDRA (Drug) $410.75
- INVELTYS (Drug) $281.80
- ILUX (Device) $262.07
- VYZULTA (Drug) $198.89
- XDEMVY (Drug) $194.55
- RESTASIS (Drug) $192.63
- EYSUVIS (Drug) $172.05
- Rhopressa (Drug) $165.06
- LIPIFLOW SYSTEM ACTIVATOR II (DISPOSABLE (Device) $150.86
- HYDRUS Microstent (Device) $149.99
- Cequa (Drug) $149.93
- CEQUA (Drug) $146.15
- Acuvue (Device) $140.14
- Prokera (Device) $137.41
- LUMIGAN (Drug) $135.04
- COMBIGAN (Drug) $107.26
- Bromsite (Drug) $105.76
- MIEBO (Drug) $102.91
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Optometrist Doctors in Sparks
Douglas Devries, O.d, O.D
Optometrist — Payments: $1.4M
Optometrist $1.4M
Troy Humphreys, Od Faao, OD FAAO
Optometrist — Payments: $41,793
Optometrist $41,793
Dr. Evan Pritchett, Od, OD
Optometrist — Payments: $3,518
Optometrist $3,518
Timothy Huntting, Od, OD
Optometrist — Payments: $3,425
Optometrist $3,425
Benjamin Cheung, Od, OD
Optometrist — Payments: $3,135
Optometrist $3,135
Dr. Umari Duffus, O.d, O.D
Optometrist — Payments: $1,899
Optometrist $1,899